SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: John O'Neill who wrote (20049)5/4/1998 11:23:00 PM
From: bob zagorin  Respond to of 32384
 
re: lyphoma. you might check the following inf. i posted on the genta thread. it references a release with inf. of genta's lead "anticode" compound - G3139 - which as been proven effective against the gene responsible for cancer malignancy. it is in advanced clinical trials at sloan-kettering for prostate and in europe for non-hodgkins lyphoma. you can do a search on the compound # and get a lot more background.

exchange2000.com